FDA Drug recall D-0890-2023
StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Peppermint, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-112-01
- FDA Drug
- Class II
- terminated
- Published 2023-07-05
On 2023-07-05 the FDA classified a Class II recall of StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Peppermint, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-112-01 by Homeocare Laboratories, citing cGMP deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0890-2023 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2023-06-05 |
| Published | 2023-07-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Homeocare Laboratories |
| Distribution | US |
Product
StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Peppermint, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-112-01
Reason
cGMP deviations
Identifiers
| ndc | 69685-112-01 |
|---|---|
| ndc | 69685-115-01 |
| ndc | 69685-111-01 |
| code_info | Lot #2407, exp. date Feb-24; 2409A, exp. date Apr-24; 2409B, exp. date May-24 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0890-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.